Medicare Price Negotiations and the Impact on Drug Prices and Caregiving

Consumer confidence is down but our market guest is staying positive on the markets and has one group of stocks she says is poised to benefit. Plus, the list of the first 10 drugs targeted for Medicare negotiations is out, and former FDA Commissioner Dr. Scott Gottlieb is warning of unintended consequences. And on the heels of the latest Case-Shiller housing report, Yale Professor Robert Shiller joins us to discuss the findings and where housing prices could go from here.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.